Evidence map›Paper›PMID 38348940›Full record

ArticleJournal of genetic counseling2025

Health-related quality of life and fear of progression in individuals with Li-Fraumeni syndrome.

Senta Kiermeier, Sarah Schott, Juliane Nees, Christina Dutzmann, Farina Strüwe, Christian P Kratz, Christina Sauer, Anna Fleischer, Myriam Keymling, Imad Maatouk

Open access · hybridAbstract read
In one paragraph

Article in Journal of genetic counseling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Senta KiermeierSection of Psychosomatic Medicine, Psychotherapy and Psychooncology, Department of Internal Medicine II, Julius-Maximilian University Würzburg, Würzburg, Germany.ORCID 0000-0002-5815-5713
Sarah SchottDepartment of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-1714-1147
Juliane NeesDepartment of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-4886-9808
Christina DutzmannDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Farina StrüweDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-7712-1300
Christian P KratzDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4120-5873
Christina SauerDepartment of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-3628-9056
Anna FleischerSection of Psychosomatic Medicine, Psychotherapy and Psychooncology, Department of Internal Medicine II, Julius-Maximilian University Würzburg, Würzburg, Germany.ORCID 0009-0009-8760-3931
Myriam KeymlingDepartment of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-4447-5636
Imad MaatoukSection of Psychosomatic Medicine, Psychotherapy and Psychooncology, Department of Internal Medicine II, Julius-Maximilian University Würzburg, Würzburg, Germany.ORCID 0000-0002-8030-1182
Heidelberg University · DEMedizinische Hochschule Hannover · DEUniversity of Würzburg · DEGerman Cancer Research Center · DE

Funding

Bundesministerium für Bildung und Forschung 01GM1909ABundesministerium für Bildung und Forschung 01GM1909DDeutsche Krebshilfe DKS2019.13
6 · The paper itself

Abstract

Li-Fraumeni syndrome (LFS) is a rare autosomal dominant cancer predisposition syndrome associated with a highly elevated lifetime cancer risk. This and the recommended intense surveillance program represent a large psychological burden on families. In order to develop targeted psychosocial interventions, we conducted a needs assessment. Adults (≥18 years) with LFS were included via regular hospital visits and online support groups and newsletters. Individuals filled out a questionnaire addressing among others: fear of progression (FoP-questionnaire, short-form), health-related quality of life (HRQoL, Short-Form Health Survey-12), distress (National Comprehensive Cancer Network distress thermometer), perceived cancer risk, and aspects of surveillance adherence. Collecting data over a 14-month period (March 2020 - June 2021), 70 adults were recruited (female = 58, 82.9%; mean age = 41.53 years). With mean mental component scores (MCS) of 42.28 (SD = 10.79), and physical component scores (PCS) of 48.83 (SD = 10.46), HRQoL was low in 34.8% (physical) and 59.4% (mental) of individuals when applying a mean cut-off of 45.4 (PCS) and 47.5 (MCS) to indicate poor HRQoL. High levels of FoP and distress were present in 68.6% and 69.1% of the participants, respectively. Performing a multiple linear regression on MCS and PCS, no sociodemographic variable was shown to be significant. FoP (β = -0.33, p < 0.05) and distress (β = -0.34, p < 0.05) were significantly associated with MCS. Individuals in our sample were burdened more than expected, with the majority reporting low levels of (mental) HRQoL, high distress, and FoP. Psychosocial support is necessary to help individuals with LFS (survivors as well as "previvors") increase their HRQoL, as it is crucial to survival.

Indexed as

FearLi-Fraumeni SyndromeQuality of LifeAdultDisease ProgressionFemaleHumansMaleMiddle AgedSurveys and Questionnairesdistressfear of progressionLi‐Fraumeni syndromemental healthpsychosocialquality of life

Identifiers

PMID38348940
PMCPMC11726407
OpenAlexW4391786214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.